AU2001240885A1 - Use of glucosylceramide synthesis inhibitors in brain cancer therapy - Google Patents
Use of glucosylceramide synthesis inhibitors in brain cancer therapyInfo
- Publication number
- AU2001240885A1 AU2001240885A1 AU2001240885A AU4088501A AU2001240885A1 AU 2001240885 A1 AU2001240885 A1 AU 2001240885A1 AU 2001240885 A AU2001240885 A AU 2001240885A AU 4088501 A AU4088501 A AU 4088501A AU 2001240885 A1 AU2001240885 A1 AU 2001240885A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer therapy
- brain cancer
- synthesis inhibitors
- glucosylceramide synthesis
- glucosylceramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0006539 | 2000-03-17 | ||
GBGB0006539.1A GB0006539D0 (en) | 2000-03-17 | 2000-03-17 | Therapies |
PCT/GB2001/001189 WO2001068093A1 (en) | 2000-03-17 | 2001-03-19 | Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001240885A1 true AU2001240885A1 (en) | 2001-09-24 |
Family
ID=9887886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001240885A Abandoned AU2001240885A1 (en) | 2000-03-17 | 2001-03-19 | Use of glucosylceramide synthesis inhibitors in brain cancer therapy |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030069200A1 (en) |
EP (1) | EP1263436A1 (en) |
JP (1) | JP2003534244A (en) |
AU (1) | AU2001240885A1 (en) |
GB (1) | GB0006539D0 (en) |
WO (1) | WO2001068093A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005123055A2 (en) * | 2004-06-14 | 2005-12-29 | Musc Foundation For Research Development | Methods for treating inflammatory disorders |
JPWO2006028241A1 (en) * | 2004-09-08 | 2008-05-08 | 武田薬品工業株式会社 | Pharmaceuticals for prevention and treatment of arteriosclerosis |
WO2007062073A2 (en) * | 2005-11-23 | 2007-05-31 | Trustees Of Boston College | Models of metastatic tumors |
GB0614098D0 (en) * | 2006-07-15 | 2006-08-23 | Mnl Pharma Ltd | Immune response variegation with imino sugars |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837237A (en) * | 1985-07-09 | 1989-06-06 | Fred Hutchinson Cancer Research Center | Therapy using glucosidase processing inhibitors |
CA2086413A1 (en) * | 1990-06-29 | 1991-12-30 | Yohji Ezure | Piperidine derivatives |
US5399567A (en) * | 1993-05-13 | 1995-03-21 | Monsanto Company | Method of treating cholera |
EP1030839B1 (en) * | 1997-11-10 | 2004-02-04 | G.D. SEARLE & CO. | Use of alkylated iminosugars to treat multidrug resistance |
DK1091745T3 (en) * | 1998-06-29 | 2008-12-15 | Los Angeles Childrens Hospital | Treatment of hyperproliferative disorders |
WO2000056334A1 (en) * | 1999-03-19 | 2000-09-28 | The Trustees Of Boston College | Use of imino sugars for anti-tumor therapy |
GB9909066D0 (en) * | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
-
2000
- 2000-03-17 GB GBGB0006539.1A patent/GB0006539D0/en not_active Ceased
-
2001
- 2001-03-19 JP JP2001566657A patent/JP2003534244A/en not_active Withdrawn
- 2001-03-19 AU AU2001240885A patent/AU2001240885A1/en not_active Abandoned
- 2001-03-19 EP EP01911967A patent/EP1263436A1/en not_active Withdrawn
- 2001-03-19 WO PCT/GB2001/001189 patent/WO2001068093A1/en not_active Application Discontinuation
-
2002
- 2002-09-13 US US10/244,047 patent/US20030069200A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030069200A1 (en) | 2003-04-10 |
GB0006539D0 (en) | 2000-05-10 |
WO2001068093A1 (en) | 2001-09-20 |
EP1263436A1 (en) | 2002-12-11 |
JP2003534244A (en) | 2003-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145907A0 (en) | Use of glucosylceramide synthesis inhibitors in therapy | |
IL166780A0 (en) | Use of ikappab-kinase inhibitors in pain therapy | |
AU2002339157A1 (en) | Inhibitors of the notch signalling pathway for use in the treatment of cancer | |
IL148719A0 (en) | Kinase inhibitors as therapeutic agents | |
AU2002226069A1 (en) | Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
HUP0200819A3 (en) | Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk | |
AU2001269046A1 (en) | Use of therapeutic benzamide derivatives | |
EP1435988A4 (en) | Improved use of antitumoral compound in cancer therapy | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
HUP0300005A3 (en) | Modified cytokines for use in cancer therapy | |
EP1463495A4 (en) | Agents and methods for treatment of cancer | |
AU2001266838A1 (en) | Inhibitors of matriptase for the treatment of cancer | |
EP1349485A4 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001232060A1 (en) | Use of cyp1b1 inhibitors for treating cancer | |
AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
IL131047A0 (en) | Use of il-18 inhibitors | |
AU2001240885A1 (en) | Use of glucosylceramide synthesis inhibitors in brain cancer therapy | |
IL149722A0 (en) | Device for radial in depth skin therapy | |
AU2001276462A1 (en) | Use of natural products in cancer treatment | |
AU2001284743A1 (en) | Therapeutic topical solution for skin and associated methods of use | |
AU2001280443A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
HUP0402664A3 (en) | 2-indanylamino derivatives for the therapy of chronic pain | |
AU2002350513A1 (en) | Use of solasonine for the treatment of skin tumors | |
AU2001271261A1 (en) | Therapeutic treatment of cancer with a protein kinase c inhibitor |